Entry |
|
Name |
|
Formula |
C20H28O2
|
Exact mass |
300.2089
|
Mol weight |
300.4351
|
Structure |

|
Remark |
|
Reaction |
|
Pathway |
map04672 | Intestinal immune network for IgA production |
map04920 | Adipocytokine signaling pathway |
|
Enzyme |
|
Brite |
Lipids [BR:br08002]
PR Prenol lipids
PR01 Isoprenoids
PR0109 Retinoids
C15493 9-cis-Retinoic acid
Target-based classification of compounds [BR:br08010]
Nuclear receptors
Thyroid hormone like receptors
Retinoic acid receptor
NR1B; nuclear receptor, subfamily 1, group B
C15493 9-cis-Retinoic acid
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
D DERMATOLOGICALS
D11 OTHER DERMATOLOGICAL PREPARATIONS
D11A OTHER DERMATOLOGICAL PREPARATIONS
D11AH Agents for dermatitis, excluding corticosteroids
D11AH04 Alitretinoin
D02815 Alitretinoin (USAN) <US>
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01X OTHER ANTINEOPLASTIC AGENTS
L01XF Retinoids for cancer treatment
L01XF02 Alitretinoin
D02815 Alitretinoin (USAN) <US>
USP drug classification [BR:br08302]
Antineoplastics
Retinoids
Alitretinoin
D02815 Alitretinoin (USAN)
Target-based classification of drugs [BR:br08310]
Nuclear receptors
Thyroid hormone like receptors
Retinoic acid receptor (RAR)
NR1B (RAR)
D02815 Alitretinoin (USAN) <US>
Hepatocyte nuclear factor 4 like receptors
Retinoid X receptor (RXR)
NR2B (RXR)
D02815 Alitretinoin (USAN) <US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D02815
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D02815
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D02815
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 22
1 C2y C 17.3247 -15.7429
2 C1z C 17.3247 -17.1420
3 C2y C 16.1099 -15.0496
4 C2b C 18.5202 -15.0434
5 C1x C 16.1099 -17.8480
6 C1a C 17.8603 -18.7470
7 C1a C 18.6474 -17.4919
8 C1x C 14.9143 -15.7429
9 C1a C 16.1035 -13.6632
10 C2b C 19.7224 -15.7366
11 C1x C 14.9143 -17.1420
12 C2c C 20.9178 -15.0369
13 C2b C 22.1136 -15.7302
14 C1a C 20.9116 -13.6570
15 C2b C 22.1138 -17.1500
16 C2b C 23.3231 -17.8554
17 C2c C 23.3168 -19.2554
18 C2b C 24.5261 -19.9608
19 C6a C 24.5199 -21.3607
20 O6a O 23.2942 -22.0613
21 O6a O 25.7097 -22.0547
22 C1a C 22.0985 -19.9516
BOND 22
1 1 2 1
2 1 3 2
3 1 4 1
4 2 5 1
5 2 6 1
6 2 7 1
7 3 8 1
8 3 9 1
9 4 10 2
10 5 11 1
11 10 12 1
12 12 13 2
13 12 14 1
14 8 11 1
15 13 15 1
16 15 16 2
17 16 17 1
18 17 18 2
19 18 19 1
20 19 20 1
21 19 21 2
22 17 22 1
|